UBS Group’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.2K Sell
8,673
-26,894
-76% -$50.3K ﹤0.01% 7264
2025
Q1
$63.3K Sell
35,567
-23,607
-40% -$42K ﹤0.01% 6118
2024
Q4
$187K Buy
59,174
+8,467
+17% +$26.7K ﹤0.01% 5290
2024
Q3
$104K Sell
50,707
-19,658
-28% -$40.5K ﹤0.01% 5137
2024
Q2
$103K Buy
70,365
+49,654
+240% +$72.5K ﹤0.01% 5012
2024
Q1
$48.5K Buy
20,711
+2,951
+17% +$6.91K ﹤0.01% 5363
2023
Q4
$35.9K Buy
17,760
+8,634
+95% +$17.4K ﹤0.01% 5538
2023
Q3
$44.2K Sell
9,126
-139
-2% -$673 ﹤0.01% 5238
2023
Q2
$63.4K Buy
9,265
+2,841
+44% +$19.4K ﹤0.01% 5282
2023
Q1
$46.5K Buy
6,424
+1,399
+28% +$10.1K ﹤0.01% 5427
2022
Q4
$64.5K Buy
+5,025
New +$64.5K ﹤0.01% 5386
2022
Q3
Sell
-16,434
Closed -$202K 9806
2022
Q2
$202K Sell
16,434
-40,250
-71% -$495K ﹤0.01% 3930
2022
Q1
$961K Buy
56,684
+32,590
+135% +$553K ﹤0.01% 3266
2021
Q4
$581K Buy
24,094
+23,854
+9,939% +$575K ﹤0.01% 3857
2021
Q3
$7K Buy
240
+227
+1,746% +$6.62K ﹤0.01% 7190
2021
Q2
$0 Sell
13
-198
-94% ﹤0.01% 8658
2021
Q1
$4K Sell
211
-1,243
-85% -$23.6K ﹤0.01% 7399
2020
Q4
$21K Buy
1,454
+1,441
+11,085% +$20.8K ﹤0.01% 5910
2020
Q3
$0 Hold
13
﹤0.01% 7451
2020
Q2
$0 Sell
13
-1,079
-99% ﹤0.01% 7368
2020
Q1
$9K Buy
1,092
+823
+306% +$6.78K ﹤0.01% 6110
2019
Q4
$2K Sell
269
-894
-77% -$6.65K ﹤0.01% 6780
2019
Q3
$12K Buy
1,163
+219
+23% +$2.26K ﹤0.01% 6101
2019
Q2
$13K Buy
944
+561
+146% +$7.73K ﹤0.01% 6034
2019
Q1
$5K Buy
383
+200
+109% +$2.61K ﹤0.01% 6357
2018
Q4
$5K Buy
183
+118
+182% +$3.22K ﹤0.01% 6638
2018
Q3
$3K Buy
+65
New +$3K ﹤0.01% 6748